In the field of gynecology, the prothrombin gene mutation is significant because it can complicate various aspects of women's health, particularly during pregnancy and the use of hormonal contraceptives. Women with this mutation are at a higher risk for venous thromboembolism (VTE), which includes conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE).
